Uracil + Tegafur	Observation	Anemia 	10387	10557	Anemia and increased ALP in any grade occurred more often in the UFT group than in the OBS group (respectively, 41.4% versus 6.9%, P = 0.0049; 24.1% versus 0%, P = 0.01).
Uracil + Tegafur	Observation	Grade 3 diarrhea	10558	10663	Grade 3 diarrhea was increased in the UFT group, but this was not significant (6.9% versus 0%, P = 0.49).
Uracil + Tegafur	Observation	Overall survival	8444	8577	The median OS was 14.2 months (95% CI, 11.1-17.3) with the UFT group and 14.2 months (95% CI, 8.2-20.3) with the OBS group (P = 0.983
Uracil + Tegafur	Observation	Overall survival	8444	8578	The median OS was 14.2 months (95% CI, 11.1-17.3) with the UFT group and 14.2 months (95% CI, 8.2-20.3) with the OBS group (P = 0.983,
Uracil + Tegafur	Observation	Anemia 	10387	10556	Anemia and increased ALP in any grade occurred more often in the UFT group than in the OBS group (respectively, 41.4% versus 6.9%, P = 0.0049; 24.1% versus 0%, P = 0.01)
Uracil + Tegafur	Observation	Grade 3 diarrhea	10558	10662	Grade 3 diarrhea was increased in the UFT group, but this was not significant (6.9% versus 0%, P = 0.49)
